Larimar Therapeutics, Inc.盘中异动大幅跳水36.14%报3.94美元_老虎社区_美港股上老虎

Larimar Therapeutics, Inc.盘中异动大幅跳水36.14%报3.94美元

市场透视2024-12-16

北京时间2024年12月16日22时31分，Larimar Therapeutics, Inc.（LRMR.us）股票出现异动，股价大幅下跌36.14%。截至发稿，该股报3.94美元/股，成交量92.3119万股，换手率1.45%，振幅1.59%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-15.50百万美元，每股收益-0.24美元，毛利-74000.00美元，市盈率-3.43倍。...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

暂无评论

热议股票

7x24

全部

{"i18n":{"language":"zh_CN"},"data":{"share":"https://www.laohu8.com/m/news/2491134694?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2024-12-16 22:31","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2491134694","market":"us","top_or_hot":-1,"title":"Larimar Therapeutics, Inc.盘中异动 大幅跳水36.14%报3.94美元","media":"市场透视","content":"<div>\n<p>北京时间2024年12月16日22时31分，Larimar Therapeutics, Inc.（LRMR.us）股票出现异动，股价大幅下跌36.14%。截至发稿，该股报3.94美元/股，成交量92.3119万股，换手率1.45%，振幅1.59%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-15.50百万美元，每股收益-0.24美元，毛利-74000.00美元，市盈率-3.43倍。...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241216223116a1f34279&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Larimar Therapeutics, Inc.盘中异动 大幅跳水36.14%报3.94美元</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nLarimar Therapeutics, Inc.盘中异动 大幅跳水36.14%报3.94美元\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-12-16 22:31 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241216223116a1f34279&s=b><strong>市场透视</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>北京时间2024年12月16日22时31分，Larimar Therapeutics, Inc.（LRMR.us）股票出现异动，股价大幅下跌36.14%。截至发稿，该股报3.94美元/股，成交量92.3119万股，换手率1.45%，振幅1.59%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-15.50百万美元，每股收益-0.24美元，毛利-74000.00美元，市盈率-3.43倍。...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241216223116a1f34279&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LRMR","symbol_name":"Larimar Therapeutics, Inc.","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241216223116a1f34279&s=b","article_id":"2491134694","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241216223116a1f34279&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2491134694","pubTimestamp":1734359476,"columns":[],"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"北京时间2024年12月16日22时31分，Larimar Therapeutics, Inc.股票出现异动，股价大幅下跌36.14%。Larimar Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.02%。Larimar Therapeutics, Inc.公司简介：Larimar Therapeutics Inc 是一家处于临床阶段的生物技术公司，专注于利用新型细胞穿透肽技术平台为复杂罕见疾病患者开发治疗方法。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"LRMR":"Larimar Therapeutics, Inc.","BK4139":"生物科技","LENZ":"Therapeutics"},"translate_title":"Larimar Therapeutics, Inc. plunged 36.14% to $3.94 in intraday movements","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"LRMR":1,"LENZ":1},"content_text":"北京时间2024年12月16日22时31分，Larimar Therapeutics, Inc.（LRMR.us）股票出现异动，股价大幅下跌36.14%。截至发稿，该股报3.94美元/股，成交量92.3119万股，换手率1.45%，振幅1.59%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-15.50百万美元，每股收益-0.24美元，毛利-74000.00美元，市盈率-3.43倍。机构评级方面，在所有11家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。Larimar Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.02%。其相关个股中，Nrx Pharmaceuticals Inc C/Wts 24/05/2026 (To Pur Com)、Tonix Pharmaceuticals Holding Corp.、Viridian Therapeutics, Inc.涨幅较大，Dermata Therapeutics, Inc.、Tonix Pharmaceuticals Holding Corp.、Genprex, Inc.较为活跃，换手率分别为29.10%、27.58%、20.42%，振幅较大的相关个股有Tonix Pharmaceuticals Holding Corp.、X4制药、Aprea Therapeutics, Inc.，振幅分别为5.74%、5.70%、5.63%。Larimar Therapeutics, Inc.公司简介：Larimar Therapeutics Inc 是一家处于临床阶段的生物技术公司，专注于利用新型细胞穿透肽技术平台为复杂罕见疾病患者开发治疗方法。该公司的主要候选产品CTI-1601是一种皮下给药的重组融合蛋白，旨在传递一种人体共济失调患者线粒体中的必需蛋白，即frataxin (FXN)。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-2","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"hasMoreComments":false,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"isCrawlerRequest":true}